The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Global Medical REIT Inc (NYSE: GMRE) closed at $7.27 up 1.68% from its previous closing price of $7.15. In other words, the price has increased by $1.68 from its previous closing price. On the day, 0.44 million shares were traded. GMRE stock price reached its highest trading level at $7.28 during the session, while it also had its lowest trading level at $7.135.
Ratios:
For a deeper understanding of Global Medical REIT Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.95 and its Current Ratio is at 0.95. In the meantime, Its Debt-to-Equity ratio is 1.34 whereas as Long-Term Debt/Eq ratio is at 1.31.
On October 18, 2024, Berenberg started tracking the stock assigning a Buy rating and target price of $11.75.
On September 19, 2024, Alliance Global Partners started tracking the stock assigning a Buy rating and target price of $12.Alliance Global Partners initiated its Buy rating on September 19, 2024, with a $12 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 24 ’25 when Decker Mark Okey Jr bought 102,668 shares for $6.52 per share. The transaction valued at 669,694 led to the insider holds 102,668 shares of the business.
Decker Mark Okey Jr bought 57,332 shares of GMRE for $372,834 on Jun 25 ’25. The CEO and President now owns 160,000 shares after completing the transaction at $6.50 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMRE now has a Market Capitalization of 988698112 and an Enterprise Value of 1228325632. As of this moment, Global’s Price-to-Earnings (P/E) ratio for their current fiscal year is 232.27, and their Forward P/E ratio for the next fiscal year is 207.71. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.42 while its Price-to-Book (P/B) ratio in mrq is 1.10. Its current Enterprise Value per Revenue stands at 8.887 whereas that against EBITDA is 14.486.
Stock Price History:
The Beta on a monthly basis for GMRE is 1.19, which has changed by -0.19222224 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, GMRE has reached a high of $10.35, while it has fallen to a 52-week low of $6.05. The 50-Day Moving Average of the stock is 7.03%, while the 200-Day Moving Average is calculated to be -10.49%.
Shares Statistics:
For the past three months, GMRE has traded an average of 724.84K shares per day and 1090940 over the past ten days. A total of 66.88M shares are outstanding, with a floating share count of 62.94M. Insiders hold about 5.89% of the company’s shares, while institutions hold 68.51% stake in the company. Shares short for GMRE as of 1749772800 were 2001652 with a Short Ratio of 2.76, compared to 1747267200 on 1781587. Therefore, it implies a Short% of Shares Outstanding of 2001652 and a Short% of Float of 3.18.
Dividends & Splits
According to the company, the forward annual dividend rate for GMRE is 0.67, from 0.84 in the trailing year. Against a Trailing Annual Dividend Yield of 0.11748251The stock’s 5-year Average Dividend Yield is 7.83.
